Live Breaking News & Updates on Total functional capacity

Stay updated with breaking news from Total functional capacity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

uniQure Announces Update on U.S. Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington's Disease

uniQure Announces Update on U.S. Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington's Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Amsterdam , Noord-holland , Netherlands , Chiara-russodirect , Sarah-tabrizi , Mariae-cantordirect , Ricardo-dolmetsch , Tom-malonedirect , Huntington-disease-center , Cure-huntington-disease-initiative , Phasei-ii-clinical-program , Squre-inc

UniQure Announces Update on U.S. Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington's Disease

~ AMT-130 continues to be generally well-tolerated across both dose cohorts ~ ~ Patients treated with AMT-130 show preserved function compared to baseline and clinical benefits relative to natural. | June 21, 2023 ....

Amsterdam , Noord-holland , Netherlands , Tom-malone , Ricardo-dolmetsch , Sarah-tabrizi , Chiara-russo , Mariae-cantor , Huntington-disease-center , University-college-london , Phasei-ii-clinical-program , Securities-exchange

uniQure Announces Update on U.S. Phase I/II Clinical Trial

~ AMT-130 continues to be generally well-tolerated across both dose cohorts ~ ~ Patients treated with AMT-130 show preserved function compared to baseline. ....

Amsterdam , Noord-holland , Netherlands , Ricardo-dolmetsch , Tom-malone , Mariae-cantor , Chiara-russo , Sarah-tabrizi , Securities-exchange , Cure-huntington-disease-initiative , Huntington-disease-center , University-college-london

Why UniQure Stock Is Trading Down Today - uniQure (NASDAQ:QURE)

UniQure N.V. (NASDAQ: QURE) shares are lower after the company announced interim data from the Phase I/II trial of AMT-130 in Huntington's Disease. ....

Ricardo-dolmetsch , Patrick-trucchio , Hc-wainwright-co , Total-motor-score , Total-functional-capacity , Unified-huntington , Disease-rating-scale ,

Huntington Disease Staging System May Pave Way for Clinical Trials During Early Stage

The Huntington Disease Integrated Staging System can help with the early study of the disease and the design of clinical trials for drug safety and efficacy. ....

Movement-disorder-society , Hd-regulatory-science-consortium , Regulatory-science-forum , Total-motor-score , Symbol-digit-modalities-test , Total-functional-capacity , Independence-scale ,